The anti-tumour antibody SF-25 IgE was successful in engaging all three macrophage subsets, M0, M1 and M2 to mediate tumour antigen-specific ADCC of A-2058 cancer cells compared with non-specific antibody-treated or no antibody control cells (Fig. 6B). The gene discussed is IGHE; the disease is cancer.